Printer Friendly

Browse Drug approval topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Diclegis for Morning Sickness Now Available Through Texas Fee-For-Service Medicaid Program. Medical condition overview Jan 22, 2015 1330
Astellas Announces FDA Anti-Infective Drugs Advisory Committee Recommends Approval of CRESEMBA (isavuconazonium) for Treatment of Invasive Aspergillosis and Mucormycosis. Jan 22, 2015 664
United States : FDA approves new psoriasis drug Cosentyx. Jan 22, 2015 456
Switzerland : Novartis announces FDA approval for first IL-17A antagonist Cosentyx(TM) (secukinumab) for moderate-to-severe plaque psoriasis patients. Jan 22, 2015 435
United States : Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy. Jan 21, 2015 344
Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients. Jan 21, 2015 776
Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients. Jan 21, 2015 804
Belgium : Boehringer Ingelheim wins EC approval for drug to treat rare lung disease. Jan 20, 2015 167
United States : FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 20, 2015 426
FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 19, 2015 2435
United Kingdom : European Commission approves new rural fuel tax cut. Jan 16, 2015 480
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) for the Treatment of Chronic Hepatitis C. Jan 16, 2015 2161
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) for the Treatment of Chronic Hepatitis C. Jan 16, 2015 2140
AbbVie Announces U.S. FDA Approval of DUOPA(TM) (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease. Jan 16, 2015 1931
Hemlock extra large clips hemlock extra large clips, us fda approved quality, each set having 14 strips of 6 clips each. Jan 16, 2015 218
Hemolok extra large 5 mm endo applier 32.5cm, 5 mm diameter hemolok extra large 5 mm endo applier 32.5cm, 5 mm diameter us fda approved quality, one piece. Jan 16, 2015 227
Hemlock large clips, hemlock large clips, us fda approved quality, each set having 14 strips of 6 clips each. Jan 16, 2015 216
Hemo lok ml endo remover for l/xl us fda approved quality. Jan 16, 2015 223
Mylan Launches Generic Epivir-HBV Tablets. Jan 15, 2015 402
Veloxis Confirms Receipt of U.S. Food and Drug Administration Decision. Jan 13, 2015 554
AbbVie Announces U.S. FDA Approval of DUOPA(TM) (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease. Jan 12, 2015 1879
Drugs alone can't fight diabetes. Jan 12, 2015 1176
Japan : U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA(edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism. Jan 9, 2015 458
United States : FDA approves anti-clotting drug Savaysa. Jan 9, 2015 481
Impax Pharmaceuticals Announce FDA Approval of RYTARY(TM) (Carbidopa and Levodopa) Extended-Release Capsules for the Treatment of Parkinson's disease. Jan 8, 2015 2604
PCMA Statement on the FDA Advisory Committee's Vote to Approve the First U.S. Biosimilar. Jan 8, 2015 354
U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism. Jan 8, 2015 4096
Bellafill Receives FDA Approval For Treatment Of Acne Scars. Jan 6, 2015 1209
Mylan Launches Generic Diovan Tablets. Jan 5, 2015 425
United States : NAMZARIC gets FDA approval. Jan 2, 2015 184
FDA APPROVES TWO HIGHER DOSAGE STRENGTHS OF ZUBSOLV. Jan 1, 2015 368
Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dyloject(TM)(diclofenac sodium) Injection. Dec 30, 2014 1493
United States : FDA approval for Namzaric to treat dementia obtained by Actavis and Adamas. Dec 29, 2014 289
United States : US FDA approval for Epivir tabs obtained by Lupin. Dec 29, 2014 118
Providing of Pharmaceutical products. Dec 27, 2014 530
Providing of Pharmaceutical products. Dec 27, 2014 522
United States : FDA Approval Of Namzaric in dementia declared by Actavis and Adamas. Dec 26, 2014 131
United States : FDA approval secured by New drug combo to treat UTIs, intra-abdominal infections. Dec 26, 2014 129
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride. Dec 24, 2014 1717
Novo Nordisk receives FDA approval for Saxenda (liraglutide [rDNA origin] injection) for chronic weight management. Dec 24, 2014 2372
United States : FDA approves new flu drug from DURHAM. Dec 24, 2014 249
United States : BIOCRYST gets FDA approval for first intravenous flu drug. Dec 24, 2014 177
United States : FDA approves weight-management drug Saxenda. Dec 24, 2014 459
Personalized Cancer Vaccine Moves to Phase IIb Trial at Leading U.S. Cancer Hospitals. Dec 23, 2014 696
Taiho Oncology Completes Submission of TAS-102 New Drug Application to the US Food and Drug Administration for the Treatment of Refractory Metastatic Colorectal Cancer. Dec 22, 2014 1056
United States : FDA approves Viekira Pak to treat hepatitis C. Dec 20, 2014 458
United States : FDA approves new antibacterial drug Zerbaxa. Dec 20, 2014 414
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK(TM) (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C. Dec 19, 2014 2442
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK(TM) (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C. Dec 19, 2014 2461
Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze (asparaginase Erwinia chrysanthemi). Dec 19, 2014 1131
Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze (asparaginase Erwinia chrysanthemi). Dec 19, 2014 1102
Switzerland : Novartis gains FDA approval for Signifor LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder. Dec 17, 2014 440
Lilly's CYRAMZA (ramucirumab) Receives Third FDA Approval. Dec 16, 2014 4306
Veloxis announces that it has filed an action against the Food and Drug Administration, seeking an order requiring FDA to grant final approval to Envarsus XR. Dec 16, 2014 464
Novartis gains FDA approval for Signifor LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder. Dec 16, 2014 3055
CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) for Hemophilia B Patients. Dec 16, 2014 987
United States : FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer. Dec 13, 2014 457
United States : Medtronic Receives FDA Approval and Launches Two New Cardiac Resynchronization Therapy Quadripolar Leads. Dec 12, 2014 399
TWi Biotechnology Receives Approval of Protocol for Its Drug AC-201 Controlled-Release Tablet, Phase II Clinical Trial in Both the United States and Taiwan. Dec 12, 2014 676
To Mitigate Risk of Infusion Reactions with Krystexxa, Serum Urate Should be Used as a Predictive Marker. Dec 12, 2014 1429
United States : FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. Dec 11, 2014 494
Mylan Launches First Generic Version of Orapred ODT. Dec 11, 2014 426
Mylan Launches Generic Robaxin Injection. Dec 11, 2014 415
MD Anderson officials react to FDA Approval of Gardasil 9 for the prevention of certain cancers. Dec 11, 2014 652
RELIEF AS LEUKAEMIA DRUG GETS APPROVED; Therapy could cut cancer death toll by 59 per cent, trials show. Dec 9, 2014 309
Daiichi Sankyo Launches New Formulation of LIXIANA 60 mg Tablets (edoxaban) in Japan. Dec 8, 2014 2193
Daiichi Sankyo Launches New Formulation of LIXIANA 60 mg Tablets (edoxaban) in Japan. Dec 8, 2014 2233
FDA Approves Amgen's XGEVA (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy. Dec 8, 2014 2705
Otsuka: U.S. FDA Approves Labeling Update of Abilify Maintena (Aripiprazole). Dec 8, 2014 128
New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA (Pembrolizumab) For Advanced Melanoma. Dec 8, 2014 2463
United States : FDA approves Jakafi to treat patients with a chronic type of bone marrow disease. Dec 5, 2014 452
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam. Dec 5, 2014 1179
United States : FDA Approves BLINCYTO (blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia. Dec 4, 2014 197
FDA Approves BLINCYTO(TM) (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Dec 3, 2014 3471
The Leukemia & Lymphoma Society Applauds FDA Approval of Blinatumomab To Treat Patients with Acute Lymphoblastic Leukemia. Dec 3, 2014 608
Diclegis for Morning Sickness Now Available Through Tennessee's Fee-For-Service Medicaid Program. Medical condition overview Dec 2, 2014 1337
Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid 1.5% w/w. Dec 2, 2014 773
Synageva BioPharma Completes Rolling Submission Of Biologics License Application To The FDA For Sebelipase Alfa And Submits Marketing Authorization Application To European Medicines Agency. Dec 2, 2014 1118
United States : HeartFlow FFR-CT software wins marketing approval from FDA. Dec 2, 2014 229
Telesta Therapeutics Announces Key Clinical & Corporate Updates. Dec 1, 2014 864
Sunscreen act reaches president's desk. Dec 1, 2014 129
Whistle blower protections and the false claims Act. Bondi, Pam Dec 1, 2014 623
European Commission Approves Trulicity (dulaglutide) Solution for Injection, Lilly's Once-Weekly, Ready-to-Use Type 2 Diabetes Treatment. Nov 25, 2014 1101
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris. Nov 25, 2014 962
Switzerland : Novartis drug Signifor approved in EU, marking an advance for patients with inadequately controlled acromegaly. Nov 25, 2014 428
IGI Laboratories, Inc. Announces ANDA Submission. Nov 24, 2014 559
United States : MERRIMACK PHARMACEUTICALS begins application of approval of cancer drug. Nov 24, 2014 182
United States : FDA approves extended-release, single-entity hydrocodone product with abuse-deterrent properties. Nov 21, 2014 436
Purdue Pharma L.P. Receives FDA Approval for Hysingla(TM) ER (hydrocodone bitartrate) Extended-Release Tablets CII, A Once-Daily Opioid Analgesic Formulated with Abuse-Deterrent Properties. Nov 20, 2014 2779
JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation. Nov 20, 2014 913
JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation. Nov 20, 2014 909
Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S. Chronology Nov 20, 2014 1625
Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate. Nov 19, 2014 2431
MPs approve bill allowing to open drug market of Kyrgyzstan for cheap generics. Nov 18, 2014 170
Robbins Arroyo LLP Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT) on Behalf of Shareholders. Nov 18, 2014 540
White Paper: How FDA Can Increase Competition Among Brand, Generic and Specialty Medications. Nov 17, 2014 526
United States : US FDA approval gained by Par Pharmas vasopressin injection. Nov 15, 2014 194
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sarepta Therapeutics, Inc. (SRPT) To Contact The Firm. Nov 14, 2014 440
United States : FDA grants approval to PAR PHARMACEUTICAL for new drug application. Nov 14, 2014 143
United States : U.S. FDA Approves Supplemental New Drug Applications for Once-Monthly Long-Acting Therapy INVEGA SUSTENNA (paliperidone palmitate) for the Treatment of Schizoaffective Disorder. Nov 14, 2014 413
Cell Source's Megadose Drug Combination Receives Regulatory Approval in Italy to Commence Human Clinical Trials. Nov 13, 2014 882
U.S. FDA Approves Supplemental New Drug Applications for Once-Monthly Long-Acting Therapy INVEGA SUSTENNA (paliperidone palmitate) for the Treatment of Schizoaffective Disorder. Nov 13, 2014 2631
Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP). Nov 12, 2014 363
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aeterna Zentaris Inc. (AEZS) To Contact The Firm. Nov 11, 2014 429
Endo Receives Final Approval for Generic Version of Valcyte. Nov 10, 2014 501
Endo Receives Final Approval for Generic Version of Valcyte. Nov 10, 2014 507
Providing of Pharmaceutical products. Nov 8, 2014 529
Providing of Pharmaceutical products. Nov 8, 2014 518
Switzerland : Novartis announces outcome of FDA advisory committee meeting for multiple myeloma investigational compound LBH589. Nov 7, 2014 212
FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen[TM] NDA in Adult Growth Hormone Deficiency. Nov 6, 2014 905
Mylan Launches Generic Loestrin 24 Fe. Nov 5, 2014 422
Ranbaxy Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg. Nov 5, 2014 613
Lilly's CYRAMZA (ramucirumab) in Combination with Paclitaxel Granted FDA Approval for Advanced Gastric Cancer After Prior Chemotherapy. Nov 5, 2014 3858
OLYSIO (simeprevir) Gains Additional FDA Approval as Once-Daily, All-Oral Interferon- and Ribavirin-Free Treatment Option in Combination with Sofosbuvir for Adults with Genotype 1 Chronic Hepatitis C Infection. Nov 5, 2014 3549
Glenmark Generics Receives Final ANDA Approval for Omeprazole DR Capsules. Nov 5, 2014 306
Glenmark Generics Receives Final ANDA Approval for Omeprazole DR Capsules. Nov 5, 2014 312
First FDA-Approved, Once Daily Application 5% Minoxidil Formula for Women Hits the Market. Nov 4, 2014 1095
United States : FDA approves orphan drug designation to Basilea's Isavuconazole. Nov 4, 2014 134
BioDelivery Sciences Announces the Availability of BUNAVAIL(TM) in the U.S. Nov 3, 2014 2297
FDA Grants Orphan Drug Designation to Astellas for Isavuconazole for the Treatment of Invasive Candidiasis. Nov 3, 2014 734
Taiwan Province of China,United States : US FDA gives approval to TWi Pharmaceuticals on ANDA. Nov 3, 2014 106
FDA panel supports retaining warning label on Chantix. Mechcatie, Elizabeth Nov 1, 2014 456
FDA approves combination pill for hepatitis C. Boschert, Sherry Nov 1, 2014 507
Veloxis announces tentative approval of Envarsus XR. Oct 31, 2014 358
TWi Pharmaceuticals Receives US FDA Approval on Generic Donepezil Hydrochloride Tablets USP, 23 mg, its fifth ANDA from US FDA. Oct 30, 2014 276
Omidria(TM) Granted Pass-Through Reimbursement Status from CMS. Oct 30, 2014 1049
TNI BioTech, Inc., through its wholly owned subsidiary TNI BioTech International Ltd., announces start of a bridging trial in Nigeria for HIV/AIDS. Oct 30, 2014 1018
HEMACORD, the First FDA-Licensed Stem Cell Product, Wins Prix Galien USA "Best Biotechnology Product" Award. Oct 30, 2014 1327
Mylan Launches Generic Viramune XR. Oct 30, 2014 420
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation. Oct 30, 2014 1779
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation. Oct 30, 2014 1776
United States : First vaccine approved by FDA to prevent serogroup B Meningococcal disease. Oct 30, 2014 441
U.S. Surgical Hemostat, Internal Tissue Sealant and Adhesion Barrier Market to Reach Nearly $2.9 Billion. Oct 29, 2014 620
The National Meningitis Association Applauds FDA Approval of First Serogroup B Meningococcal Disease Vaccine. Oct 29, 2014 471
United States : FDA approves new treatment for rare form of hemophilia. Oct 25, 2014 420
More Than 80 Experts In Male Sexual Health Pen Letter To FDA Urging Approval Of Treatment Options For Female Sexual Dysfunction. Oct 23, 2014 872
CANDA NK-2 Files Motion to Dismiss Patent Infringement Suit. Oct 22, 2014 404
Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge(TM) Surgical Leads For The Precision Spectra(TM) Spinal Cord Stimulator (SCS) System. Oct 21, 2014 1283
Switzerland : Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis. Oct 21, 2014 437
Takeda and Orexigen Announce Availability of CONTRAVE (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults. Oct 20, 2014 2769
Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA for Waldenstrom's Macroglobulinemia. Oct 20, 2014 2029
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex Recombinant. Oct 20, 2014 981
Eisai Announces FDA Acceptance of Supplemental New Drug Application for Antiepileptic Drug Perampanel as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures. Oct 20, 2014 1998
Oman's Council of Ministers discuss key issues. Oct 19, 2014 1354
United States : FDA approves labeling with abuse-deterrent features for third extended-release opioid analgesic. Oct 18, 2014 453
European Commission Approves IMBRUVICA(TM) in Two Forms of Blood Cancer. Oct 17, 2014 3143
European Commission Approves IMBRUVICA(TM) in Two Forms of Blood Cancer. Oct 17, 2014 3142
Actavis Confirms Generic Quillivant XR Patent Challenge. Oct 16, 2014 896
Esbriet (pirfenidone) receives FDA approval under 'breakthrough status'; Diplomat to distribute. Oct 16, 2014 579
Pulmonary Fibrosis Foundation Applauds The Food And Drug Administration's (FDA) Prompt Decision To Approve Esbriet (pirfenidone) And OFEV (nintedanib) For The Treatment Of Idiopathic Pulmonary Fibrosis. Oct 16, 2014 909
United States : Federal judge approves FDA consent decree with Ascend Laboratories. Oct 16, 2014 344
United States : FDA approves Ofev to treat idiopathic pulmonary fibrosis. Oct 16, 2014 362
United States : FDA approves Esbriet to treat idiopathic pulmonary fibrosis. Oct 16, 2014 363
U.S. FDA Grants Priority Review Status to NDA for Anticancer Agent Lenvatinib. Oct 15, 2014 1182
FDA Approves Boehringer Ingelheim's OFEV (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis. Oct 15, 2014 2956
What matters: license to slip up? Ebbert, Jon O. Oct 15, 2014 393
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg. Oct 14, 2014 279
U.S. FDA Approves Antiemetic Agent Akynzeo For Prevention Of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 14, 2014 882
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel. Oct 14, 2014 687
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel. Oct 14, 2014 693
United Kingdom : EUROPEAN COMMISSION approves KLESCH GROUP to buy UK refinery. Oct 14, 2014 144
FDA Approves AKYNZEO (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 13, 2014 1953
FDA Approves AKYNZEO (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 13, 2014 2136
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire. Oct 13, 2014 1623
FDA Approves AKYNZEO (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 13, 2014 1959
FDA approves $1,125 Hepatitis C Pill: FDA. Oct 11, 2014 360
Health ministry approves use of 62 new drugs. Oct 11, 2014 317
United States : FDA approves first combination pill to treat hepatitis C. Oct 11, 2014 453
United States : FDA approves a new ultrasound imaging agent. Oct 11, 2014 375
United States : FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy. Oct 11, 2014 387
Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug. Oct 10, 2014 991
Branding Campaign, Asset Sale, Executive Promotion, Clinical Data Presentation, and Drug Approval Update - Research Reports on Synchrony Financial, Avalonbay, Aflac, Teva and AstraZeneca. Oct 7, 2014 1660
Ferring Pharmaceuticals Inc. Receives FDA Approval For New Cranberry Flavor Of PREPOPIK (Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid). Oct 7, 2014 1001
HighTimes.com Features Weedhire.com Cannabis Job of the Month: October. Oct 6, 2014 599
Mylan Launches Generic Combivir. Oct 6, 2014 444
AbbVie's HUMIRA (adalimumab) Receives U.S. FDA Approval for Extension of Polyarticular Juvenile Idiopathic Arthritis Indication to Patients Ages 2 and Older. Oct 6, 2014 1551
EYLEA (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO). Oct 6, 2014 2030
BioDelivery Sciences to Provide BUNAVAIL Launch Update. Oct 6, 2014 1609
B. Braun Receives FDA Approval For New Large-Volume Injection Containers. Oct 2, 2014 738
The Majority of Surveyed Nephrologists Do Not Differentiate Among Oral HIF-PH Inhibitors in Late Stage Clinical Development. Oct 2, 2014 772
Drug quality and security act: how it's changing the practice of pharmacy and medicine. McGuff, Ronald M. Oct 1, 2014 4374
Syncope secondary to second-degree atrioventricular block with donepezil use. Hundae, Aneley; Afzal, Aasim; Assar, Manish D.; Schussler, Jeffrey M. Report Oct 1, 2014 713
United Kingdom : Hikma receives approval for colchicine 0.6mg capsules. Oct 1, 2014 138
FDA panel backs diabetes drug liraglutide for weight loss. Ault, Alicia Oct 1, 2014 891
Par Pharmaceutical Begins Shipment of Generic Exforge. Sep 30, 2014 354
Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital. Sep 30, 2014 565
Israel,United States : TEVA boosts its share price on the TASE. Sep 30, 2014 368
XTANDI (enzalutamide) receives expanded approval from FDA for treatment of metastatic castration-resistant prostate cancer. Sep 30, 2014 473
Guerbet Receives FDA's Drug Shortage Assistance Award: Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection. Sep 29, 2014 602
Switzerland : Novartis drug Signifor LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly. Sep 29, 2014 446
New Jersey Health Foundation Awards Grant to Enhance Drug Discovery at Rutgers University. Sep 26, 2014 573
AbbVie's HUMIRA (adalimumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderately to Severely Active Crohn's Disease. Sep 25, 2014 1918
Boehringer Ingelheim Announces FDA Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for the Maintenance Treatment of COPD. Sep 25, 2014 1842
Diclegis for Morning Sickness Now Available Through California and Nebraska Fee-For-Service Medicaid Programs. Medical condition overview Sep 23, 2014 1480
Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH. Sep 23, 2014 676
The crime of being in charge: executive culpability and collateral consequences. Copeland, Katrice Bridges Sep 22, 2014 19549
Is state 'right to try' legislation misguided policy? Hemphill, Thomas A. Sep 22, 2014 1229
CADTH common drug review. Smith, Stephanie Sep 22, 2014 581
Beyond Preventing Unplanned Pregnancy: The Broader Benefits of Publicly Funded Family Planning Services. Sonfield, Adam Sep 22, 2014 3254
Contraception Is Not Abortion: The Strategic Campaign of Antiabortion Groups to Persuade the Public Otherwise. Dreweke, Joerg Sep 22, 2014 4185
India,United States : FDA approves AUROBINDO PHARMA for Amoxicillin for Oral Suspension. Sep 19, 2014 164
United States : FDA approves Trulicity to treat type 2 diabetes. Sep 19, 2014 388
VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity. Sep 18, 2014 2740
FDA Approves Trulicity(TM) (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes. Sep 18, 2014 2898
United States : FDA approves MOVANTIK (naloxegol) tablets C-II for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Sep 18, 2014 358
United States : US FDA declares final permit to deal with Aurobindo's generic anti-infective drug in AMERICA. Sep 18, 2014 118
Japan : U.S. FDA Approves New Indication for the Use of XTANDI (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer. Sep 17, 2014 327
United States : FDA approves Movantik for opioid-induced constipation. Sep 17, 2014 435
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma. Sep 15, 2014 1702
Cochlear Announces the FDA Approval of True 2.4 GHz Wireless Connectivity With the Cochlear(TM) Nucleus 6 Sound Processor. Sep 15, 2014 692
United States : FDA Approves Baxter's HYQVIA for Treatment of Adults with Primary Immunodeficiency. Sep 13, 2014 254
FDA approves a new drug for weight loss. Pollack, Andrew Sep 11, 2014 502
United States : FDA approves weight-management drug Contrave. Sep 11, 2014 414
Supply of Pharmaceutical products. Sep 11, 2014 521
U.S. FDA Approves New Indication for the Use of XTANDI (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer. Sep 11, 2014 2023
Saxenda for the treatment of obesity receives positive 14-1 vote in favor of approval from FDA Advisory Committee. Sep 11, 2014 1754
New FDA-Approved Weight Loss Drug Adds New Tool for Obesity Treatment. Sep 11, 2014 474
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK. Conference news Sep 10, 2014 1582
Merck & Co.'s Keytruda is Approved in the United States for the Treatment of Advanced and Unresectable Malignant Melanoma. Sep 10, 2014 611
Diclegis (doxylamine succinate 10 mg, pyridoxine hydrochloride 10 mg) Available for Pregnant Women With Morning Sickness. Medical condition overview Sep 10, 2014 1313
U.S. FDA Approves New Indication for the Use of XTANDI (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer. Sep 10, 2014 2139
New Prevantics Device Swab from PDI Receives FDA 510k Market Authorization. Sep 9, 2014 476
FDA Advisory Committee Recommends Against Approval of Actavis' Nebivolol/Valsartan Fixed-Dose Combination NDA for Treatment of Hypertension. Sep 9, 2014 1104
FDA Approves 2 New Indications for Epaned, the First and Only Enalapril Powder for Oral Solution. Sep 8, 2014 1564
Par Pharmaceutical Resumes Shipment of Generic Precedex Injection. Sep 8, 2014 395
United States : FDA approves Keytruda for advanced melanoma. Sep 6, 2014 428
Mylan Launches Generic Boniva Injection. Sep 5, 2014 399
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher. Sep 4, 2014 1495
Cerapedics Files Premarket Approval Application with US FDA for i-FACTOR(TM) Peptide Enhanced Bone Graft. Sep 4, 2014 642
Belgium : PAGERO gets approval for e-invoicing to the EUROPEAN COMMISSION. Sep 4, 2014 108
United States : GE Healthcare Announces FDA Approval of SenoClaire, New Breast Imaging with 3D Tomosynthesis Solution. Sep 4, 2014 423
Merck Receives Accelerated Approval of KEYTRUDA (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy. Sep 4, 2014 2552
FDA Approves Pembrolizumab for Advanced Melanoma. Sep 4, 2014 706
BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell. Sep 3, 2014 1692
Sensoril Found to Support Cognitive Function in Bipolar Subjects. Sep 1, 2014 139
United States : NATCO Pharmas partner Mylan applies for Copaxone generic. Sep 1, 2014 150
New indication for VIMPAT (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures. Sep 1, 2014 4629
Advantame approved in Europe. Sep 1, 2014 267
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN. Aug 29, 2014 493
Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard. Conference news Aug 27, 2014 1488
United Kingdom : GSK receives FDA approval of an additional Promacta(eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppr. Aug 27, 2014 432
United States : STRIDES ARCOLAB obtains FDA approval for GENERIC BUSPIRONE HYDROCHLORIDE TABLETS. Aug 27, 2014 165
United States : STRIDES ARCOLAB gets approval FDA on Buspirone Hydrochloride Tablets. Aug 27, 2014 105
TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension. Aug 27, 2014 404
Tocagen Expands Clinical Development Team;. Aug 26, 2014 741
GSK receives FDA approval of an additional Promacta (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). Aug 26, 2014 2472
United States : FDA approves NIPRO DIAGNOSTICS products. Aug 26, 2014 262
United States : FDA approval for BOEHRINGER drug. Aug 23, 2014 117
Mylan Launches First Generic Klor-Con Extended-Release Tablets. Aug 22, 2014 374
Colgate Total: The Only Absolutely Safe Toothpaste Approved by FDA That Treats Gingivitis and Plaque and Doesn't Cause Cancer. Aug 22, 2014 350
United Kingdom : GSK receives FDA approval for Arnuity Ellipta (fluticasone furoate) in the USA for the treatment of asthma. Aug 22, 2014 304
United States : BMS, CELGENE announce plans to establish phase I clinical trial program. Aug 22, 2014 313
ViiV Healthcare receives FDA approval for Triumeq (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection. Aug 22, 2014 2172
ViiV Healthcare receives FDA approval for Triumeq (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection. Aug 22, 2014 2179
Actavis Confirms Generic Neupro Patent Challenge. Aug 22, 2014 953
United States : Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched it. Aug 21, 2014 248
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck. Aug 20, 2014 1662
Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic market. Aug 20, 2014 449
GSK receives FDA approval for Arnuity(TM) Ellipta (fluticasone furoate) in the US for the treatment of asthma. Aug 20, 2014 924
United States : FDA approves new drug to treat a form of Gaucher disease. Aug 20, 2014 454
Mylan Launches Generic Precedex(TM) Injection - Another Key Product Approval. Aug 19, 2014 624
Xeljanz's Label Extension to Include Reduction of Radiographic Progression of Structural Joint Damage in RA Has Positively Impacted U.S. Rheumatologists' Perceptions of This Agent. Aug 18, 2014 690
Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End. Aug 18, 2014 991
United States : B BRAUN's Nutrilipid 20% gets approval from US FDA. Aug 18, 2014 220
Cannabis-based drug is approved for use INWALES. Aug 16, 2014 613
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna. Aug 14, 2014 1627
United States : FDA approves new type of sleep drug, Belsomra. Aug 14, 2014 456
FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD. Aug 14, 2014 1485
B. Braun Receives FDA Approval for Nutrilipid 20%. Aug 13, 2014 431
AIDS activist has a new fight -- defending FDA. Perrone, Matthew Aug 12, 2014 827
Japan : FDA Approves VELCADE (bortezomib) Retreatment in Patients with Multiple Myeloma. Aug 12, 2014 440
Mylan Launches Generic Xeloda Tablets. Aug 11, 2014 581
First Varicose Vein Patient Treated with FDA-Approved Varithena (polidocanol injectable foam) 1%. Aug 11, 2014 1038
United States : U.S. FDA Approves INVOKAMET (canagliflozin/metformin HCl) for the Treatment of Adults with Type 2 Diabetes. Aug 9, 2014 440
United States : Medtronic Receives FDA Approval for Attain Performa Quadripolar Lead and Viva Quad CRT-Ds in United States. Aug 8, 2014 415
United States : FDA approves Orbactiv to treat skin infections. Aug 7, 2014 376
NextSource Biotechnology Gains FDA Approval for Use of Tradename Gleostine(TM) (Lomustine), an Anti-Cancer Chemotherapy Agent. Aug 7, 2014 439
Canada : Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market. Aug 6, 2014 375
Perlstein Lab Raises $2 Million For Orphan Drug Discovery. Aug 5, 2014 579
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market. Aug 5, 2014 1147
United States : FDA Approves Baxter's FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container. Aug 5, 2014 296
United Kingdom : FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter's HyQvia for Primary Immunodeficiency. Aug 2, 2014 277
United States : FDA approves Jardiance to treat type 2 diabetes. Aug 2, 2014 429
United States : FDA expands approval of drug to treat Pompe disease to patients of all ages; removes risk mitigation strategy requirements. Aug 2, 2014 385
FDA Approves Boehringer Ingelheim's Striverdi Respimat (olodaterol) Inhalation Spray for Maintenance Treatment of COPD. Aug 1, 2014 1508
60+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score. Aug 1, 2014 893
United States : FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease. Aug 1, 2014 411
FDA approves Jardiance (empagliflozin) tablets for adults with type 2 diabetes. Aug 1, 2014 2196
FDA approves opioid tablet that deters abuse. Karon, Amy Aug 1, 2014 199
Germany : Aflibercept Solution for Injection into the Eye Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME). Jul 31, 2014 466
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion(TM) in the new facility. Jul 30, 2014 559
United States : IMBRUVICA (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p. Jul 30, 2014 408
United States : FDA expands approved use of Imbruvica for chronic lymphocytic leukemia. Jul 30, 2014 439
FDA Performs Inspection of Impax's Taiwan Facility. Jul 29, 2014 1244
EYLEA (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME). Jul 29, 2014 2884
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA for Two Indications. Jul 28, 2014 2739
IMBRUVICA (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p. Jul 28, 2014 2907
Germany : EUROPEAN COMMISSION approves the new RENEWABLE ENERGY ACT. Jul 25, 2014 375
United Kingdom,United States : FDA approves Flonase allergy relief for sale over-the-counter in the United States. Jul 25, 2014 432
Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%. Jul 24, 2014 744

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters